Molecular etiology and pathogenesis of hereditary cardiomyopathy
- PMID: 18772524
- DOI: 10.1253/circj.cj-08-0050
Molecular etiology and pathogenesis of hereditary cardiomyopathy
Abstract
Cardiomyopathy is defined as a cardiac disease caused by functional abnormality of cardiac muscle, and the etiology of the functional abnormality includes both extrinsic and intrinsic factors. Cardiomyopathy caused by the intrinsic factors is defined as idiopathic or primary cardiomyopathy, and there are several clinical phenotypes, including hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). The major intrinsic factor is gene mutations, and linkage studies, as well as candidate gene approaches, have deciphered multiple disease genes for hereditary primary cardiomyopathy. Of note is that mutations in the same disease gene can be found in different clinical phenotypes of cardiomyopathy. Functional analyses of disease-related mutations have revealed that characteristic functional alterations are associated with the clinical phenotypes, such that increased and decreased Ca(2+) sensitivity because of sarcomere mutations are associated with HCM and DCM, respectively. In addition, recent data have suggested that mutations in the Z-disc components found in HCM and DCM may result in increased and decreased stiffness of the sarcomere (ie, stiff sarcomere and loose sarcomere, respectively). More recently, mutations in the components of the I region can be found in hereditary cardiomyopathy, further complicating the etiology of primary cardiomyopathy.
Similar articles
-
Molecular genetics and pathogenesis of cardiomyopathy.J Hum Genet. 2016 Jan;61(1):41-50. doi: 10.1038/jhg.2015.83. Epub 2015 Jul 16. J Hum Genet. 2016. PMID: 26178429 Review.
-
Molecular basis of hereditary cardiomyopathy: abnormalities in calcium sensitivity, stretch response, stress response and beyond.J Hum Genet. 2010 Feb;55(2):81-90. doi: 10.1038/jhg.2009.138. Epub 2010 Jan 15. J Hum Genet. 2010. PMID: 20075948 Review.
-
Furthering the link between the sarcomere and primary cardiomyopathies: restrictive cardiomyopathy associated with multiple mutations in genes previously associated with hypertrophic or dilated cardiomyopathy.Am J Med Genet A. 2011 Sep;155A(9):2229-35. doi: 10.1002/ajmg.a.34097. Epub 2011 Aug 5. Am J Med Genet A. 2011. PMID: 21823217 Free PMC article.
-
Molecular etiology of idiopathic cardiomyopathy in Asian populations.J Cardiol. 2001;37 Suppl 1:139-46. J Cardiol. 2001. PMID: 11433818
-
[Mutations in genes for sarcomeric proteins].Nihon Rinsho. 2000 Jan;58(1):117-22. Nihon Rinsho. 2000. PMID: 10885298 Review. Japanese.
Cited by
-
Molecular genetics and pathogenesis of cardiomyopathy.J Hum Genet. 2016 Jan;61(1):41-50. doi: 10.1038/jhg.2015.83. Epub 2015 Jul 16. J Hum Genet. 2016. PMID: 26178429 Review.
-
Disruptor of telomeric silencing 1-like (DOT1L): disclosing a new class of non-nucleoside inhibitors by means of ligand-based and structure-based approaches.J Comput Aided Mol Des. 2018 Mar;32(3):435-458. doi: 10.1007/s10822-018-0096-z. Epub 2018 Jan 15. J Comput Aided Mol Des. 2018. PMID: 29335872
-
Dysfunctional Network and Mutation Genes of Hypertrophic Cardiomyopathy.J Healthc Eng. 2022 Jan 28;2022:8680178. doi: 10.1155/2022/8680178. eCollection 2022. J Healthc Eng. 2022. PMID: 35126952 Free PMC article.
-
Phospholamban C-terminal residues are critical determinants of the structure and function of the calcium ATPase regulatory complex.J Biol Chem. 2014 Sep 12;289(37):25855-66. doi: 10.1074/jbc.M114.562579. Epub 2014 Jul 29. J Biol Chem. 2014. PMID: 25074938 Free PMC article.
-
Ablation of the cardiac-specific gene leucine-rich repeat containing 10 (Lrrc10) results in dilated cardiomyopathy.PLoS One. 2012;7(12):e51621. doi: 10.1371/journal.pone.0051621. Epub 2012 Dec 7. PLoS One. 2012. PMID: 23236519 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous